Molex Incorporated (NASDAQ: MOLX and MOLXA), a global electronic
components company, today reported results for its 2009 fourth fiscal
quarter and its full fiscal year 2009, both ended June 30, 2009.
2009 Fourth Fiscal Quarter Results
Revenue for the quarter ended June 30, 2009 of $570.6 million was at the
higher end of the range estimated in the release dated April 21, 2009
and increased 12.9% from the March 2009 quarter. Revenue decreased 34.6%
from the prior year June quarter and fell 31.4% in local currencies as
currency translation decreased revenue by $27.9 million.
Gross profit margin was 24.1%, compared with 18.5% in the March 2009
quarter, and 31.0% in the prior year June quarter. The increase in gross
profit margin from the March quarter reflects the higher revenue level
and cost savings from the previously announced restructuring program.
The decline in gross profit margin from the prior year June quarter
reflected lower absorption of manufacturing overhead resulting from
significantly lower production volume.
SG&A expense declined $2.4 million from the March quarter and $34.4
million from last year’s June quarter, due to the cost reduction actions
and additional savings from the restructuring program. Research and
development expense was $39.6 million, compared with $34.9 million in
the March 2009 quarter. The increase in research and development expense
underscores the Company’s commitment to new product development and
supports the goal of remaining a technology leader in the industry.
During fiscal 2009 the Company released 194 new products.
Net loss was $219.7 million or $1.27 per share for the quarter. Included
in the quarter results was a pretax restructuring charge of $28.0
million ($21.1 million after-tax or $0.12 per share), relating to the
restructuring program. We also recorded pretax intangible asset
impairments and other charges of $17.6 million ($11.1 million after-tax
or $0.07 per share) and a pretax and after-tax goodwill impairment
charge of $171.0 million ($0.99 per share) for our Automation &
Electrical business unit of our Custom & Electrical segment due to the
impact of the recent downturn in the industrial market. The June quarter
compares with net income of $52.6 million, or $0.29 per share in the
prior year June quarter that included a pretax restructuring charge of
$15.0 million, or approximately $0.06 per share after-tax. The effective
tax rate for the quarter was (2.1%) due primarily to the impairment of
goodwill which does not result in a tax benefit, additional tax
contingency reserves and recording valuation allowances for certain
jurisdictions with losses that may not generate realizable tax benefits.
Excluding the restructuring and impairment charges, the Company
generated a non-GAAP pretax profit of $1.3 million for the June quarter.
A complete reconciliation of this non-GAAP measure can be found on page
5.
Orders for the June quarter were $576 million, an improvement of 21%
from the March 2009 quarter, but down 33% compared with the prior year
June quarter. The Company’s order backlog at June 30, 2009 was $253
million, compared with $436 million at June 30, 2008 and $251 million at
March 31, 2009. The book-to-bill ratio was 1.01.
Capital expenditures for the June 2009 quarter were $50.3 million,
compared with $31.1 million in the March 2009 quarter and $71.2 million
in the prior year June quarter. Capital spending during the June quarter
was primarily for equipment and production tooling related to new
product development but included $14.4 million related to the
restructuring program.
Cash flow from operations was $58.3 million for the June quarter and
$369.9 million for the fiscal year ended June 30, 2009. Cash and
marketable securities were $467.9 million at June 30, 2009, a decline of
$38.0 million from March 31, 2009, though $31.1 million of cash was used
to repay debt during the June 2009 quarter.
Molex Chief Executive Officer, Martin P. Slark, commented on the
quarter, “We are encouraged by the improvement in business levels,
especially in the month of June when both revenue and orders reached
their high for the quarter. It appears that inventory reductions in our
industry’s supply chain are substantially complete, which should result
in further improvements in our business levels during the September
quarter. In addition, we have been aggressive in our response to the
business environment, including reducing our headcount by 24% over the
last three quarters and controlling capital expenditures for the year to
the lowest level since 2003. As a result, we generated significant
operating leverage during the quarter as demonstrated by the 560 basis
point sequential improvement in gross profit margin.”
Restructuring Update
The pretax restructuring charge of $28.0 million recorded in the June
quarter was primarily related to severance costs for previously
announced actions in Europe and Asia as well as an early retirement plan
in Japan that was announced in April.
The cumulative pretax restructuring charges expected to be incurred
through the end of fiscal year 2010 remains in a range of $240 to $250
million. Cumulative restructuring charges were $198 million through June
30, 2009, with the remainder to be recognized in fiscal 2010. The
expected annual cost savings from the restructuring program remains in a
range of $190 to $210 million.
Full Year Results
Revenue for the full fiscal year ended June 30, 2009 was $2.6 billion, a
decline of 22.4% compared with the prior fiscal year. During the fiscal
year, currency translation increased revenue by $5.2 million. Net loss
of $321.3 million, or $1.84 per share included a pretax restructuring
charge of $131.3 million ($99.0 million after-tax or $0.57 per share),
pretax intangible asset impairments and other charges of $20.2 million
($12.8 million after-tax or $0.7 per share), and a pretax and after-tax
goodwill impairment charge of $264.1 million ($1.51 per share). The
effective tax rate for the full year was (0.8%), due primarily to the
impairment of goodwill which does not result in a tax benefit and
recording valuation allowances for certain jurisdictions with losses
that may not generate realizable tax benefits.
Capital expenditures for fiscal 2009 were $177.9 million or 6.9% of
revenue, and included expenditures related to the restructuring program.
This compares with $234.6 million or 7.0% of revenue for the prior
fiscal year. Capital expenditures for fiscal 2009 were significantly
reduced to match demand and to maximize cash flow in this difficult
economy.
Outlook
The improved order rate during the June quarter and through July
suggests that both revenue and orders for the September quarter should
be above the June quarter level. However, as future visibility remains
limited, the Company considers it prudent to provide a relatively wide
range for its outlook, and estimates revenue in a range of $590 to $630
million for the September quarter. At this level of revenue, the Company
expects earnings per share in a range of $0.00 to $0.06, assuming an
effective tax rate of 34%. Included in these estimates is a pretax
restructuring charge of approximately $10 million or $0.04 per share
after-tax. Due to the limited visibility caused by current economic
conditions, the Company will not provide full year guidance at this time.
Earnings Webcast and August 5th
Analysts Meeting Information
A webcast will be held at 10:00am central on Wednesday, August 5th
at the start of the Molex Analysts Meeting to be held at Molex
Incorporated in Lisle, Illinois. Internet users will be able to access
the webcast live and in replay (audio and slides) for the portion of the
meeting between 10:00-11:45am central in the “Investors” section of the
Company’s website at www.molex.com.
Other Investor Events
September 10, 2009 – 2009
Citi Technology Conference in New York, NY
September 14, 2009 –
Deutsche Bank Technology Conference in San Francisco, CA
Forward-Looking Statements
Statements in this release that are not historical are
forward-looking and are subject to various risks and uncertainties that
could cause actual results to vary materially from those stated. Words
such as “anticipates,” “expects,” “believes,” “intends,” “plans,”
“projects,” “estimates,” and similar expressions are used to identify
these forward-looking statements. Forward-looking statements are
based on currently available information and include, among others, the
discussion under “Outlook.” These statements are not guarantees
of future performance and are subject to risks, uncertainties and
assumptions including those associated with the operation of our
business, including the risk that customer demand will decrease either
temporarily or permanently, whether due to the Company's actions or the
demand for the Company's products, and that the Company may not be able
to respond through cost reductions in a timely and effective manner; the
risk that the value of our inventory may decline; price cutting, new
product introductions and other actions by our competitors; fluctuations
in the costs of raw materials that the Company is not able to pass
through to customers because of existing contracts or market factors;
the availability of credit and general market liquidity; fluctuations in
currency exchange rates; the financial condition of our customers; the
challenges attendant to plant closings and restructurings, including the
difficulty of predicting plant closing and relocation costs, the
difficulty of commencing or increasing production at existing
facilities, and the reactions of customers, governmental units,
employees and other groups, the challenges attendant to plant
construction; and the ability to realize cost savings from restructuring
activities.
Other factors, risks and uncertainties are set forth in Item 1A “Risk
Factors” of the Company’s Form 10-K for the year ended June 30, 2008 and
disclosed in the Form 10-Q for the quarters ended September 30, 2008,
December 31, 2008 and March 31, 2009 which are incorporated by reference
and in other reports that Molex files or furnishes with the Securities
and Exchange Commission. Forward-looking statements are based
upon assumptions as to future events that may not prove to be accurate.
Actual outcomes and results may differ materially from what is
expressed in these forward-looking statements. As a result, this
release speaks only as of its date and Molex disclaims any obligation to
revise these forward-looking statements or to provide any updates
regarding information contained in this release resulting from new
information, future events or otherwise.
Molex Incorporated is a 71-year-old global manufacturer of
electronic, electrical and fiber optic interconnection systems. Based
in Lisle, Illinois, USA, the Company operates 43 manufacturing locations
in 18 countries. The Molex website is www.molex.com.
Editor’s note: Molex is traded on the NASDAQ Global Select Market
(MOLX and MOLXA) in the United States and on the London Stock Exchange.
The Company’s voting common stock (MOLX) is included in the S&P 500
Index.
|
Molex Incorporated
|
|
Non-GAAP Measure
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, 2009:
|
|
|
|
|
Income (loss) before income taxes (GAAP)
|
|
$
|
(215,289
|
)
|
|
Restructuring costs and asset impairments
|
|
|
45,627
|
|
|
Goodwill impairments
|
|
|
171,000
|
|
|
Non-GAAP pretax profit
|
|
$
|
1,338
|
|
Non-GAAP pretax profit is a non-GAAP financial measure. We refer to
Non-GAAP pretax profit to describe earnings excluding the items
referenced above. We believe that Non-GAAP pretax profit provides useful
information to investors because it provides information about the
estimated financial performance of Molex’s ongoing business. Non-GAAP
pretax profit is used by management in its financial and operational
decision-making and evaluation of overall operating performance and
segment level core operating performance. Non-GAAP pretax profit may be
different from similar measures used by other companies.
|
Molex Incorporated
|
|
Consolidated Balance Sheets
|
|
(in thousands, except per share data)
|
|
|
|
ASSETS
|
|
June 30,
|
|
|
|
2009
|
|
2008
|
|
Current assets:
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
424,707
|
|
$
|
475,507
|
|
Marketable securities
|
|
|
43,234
|
|
|
34,298
|
|
Accounts receivable, less allowances
|
|
|
|
|
|
of $32,593 in 2009 and $40,243 in 2008
|
|
|
528,907
|
|
|
740,827
|
|
Inventories
|
|
|
354,337
|
|
|
458,295
|
|
Deferred income taxes
|
|
|
27,939
|
|
|
23,444
|
|
Prepaid expenses
|
|
|
68,449
|
|
|
50,589
|
|
Total current assets
|
|
|
1,447,573
|
|
|
1,782,960
|
|
Property, plant and equipment, net
|
|
|
1,080,417
|
|
|
1,172,395
|
|
Goodwill
|
|
|
128,494
|
|
|
373,623
|
|
Non-current deferred income taxes
|
|
|
89,332
|
|
|
62,521
|
|
Other assets
|
|
|
196,341
|
|
|
208,038
|
|
Total assets
|
|
$
|
2,942,157
|
|
$
|
3,599,537
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
Current liabilities:
|
|
|
|
|
|
Short-term loans
|
|
$
|
224,340
|
|
$
|
66,687
|
|
Accounts payable
|
|
|
266,633
|
|
|
350,413
|
|
Accrued expenses:
|
|
|
|
|
|
Salaries, commissions and bonuses
|
|
|
55,109
|
|
|
74,689
|
|
Restructuring
|
|
|
69,928
|
|
|
19,842
|
|
Other
|
|
|
93,392
|
|
|
64,683
|
|
Income taxes payable
|
|
|
4,750
|
|
|
73,124
|
|
Total current liabilities
|
|
|
714,152
|
|
|
649,438
|
|
Other non-current liabilities
|
|
|
21,862
|
|
|
21,346
|
|
Accrued pension and other postretirement benefits
|
|
|
113,268
|
|
|
105,574
|
|
Long-term debt
|
|
|
30,311
|
|
|
146,333
|
|
Total liabilities
|
|
|
879,593
|
|
|
922,691
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
Total stockholders’ equity
|
|
|
2,062,564
|
|
|
2,676,846
|
|
Total liabilities and stockholders’ equity
|
|
$
|
2,942,157
|
|
$
|
3,599,537
|
|
Molex Incorporated
|
|
Condensed Consolidated Statements of Operations
|
|
(in thousands, except per share data)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Years Ended
|
|
|
|
June 30,
|
|
June 30,
|
|
|
|
2009
|
|
2008
|
|
2009
|
|
2008
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
Net revenue
|
|
$
|
570,589
|
|
|
$
|
871,892
|
|
$
|
2,581,841
|
|
|
$
|
3,328,347
|
|
Cost of sales
|
|
|
433,352
|
|
|
|
601,383
|
|
|
1,925,664
|
|
|
|
2,314,112
|
|
Gross profit
|
|
|
137,237
|
|
|
|
270,509
|
|
|
656,177
|
|
|
|
1,014,235
|
|
|
|
Selling, general and administrative
|
|
|
136,668
|
|
|
|
171,065
|
|
|
586,702
|
|
|
|
665,038
|
|
Restructuring costs and asset impairments
|
|
|
45,627
|
|
|
|
14,961
|
|
|
151,531
|
|
|
|
31,247
|
|
Goodwill impairments
|
|
|
171,000
|
|
|
-
|
|
|
264,140
|
|
|
-
|
|
Total operating expenses
|
|
|
353,295
|
|
|
|
186,026
|
|
|
1,002,373
|
|
|
|
696,285
|
|
|
|
Income (loss) from operations
|
|
|
(216,058
|
)
|
|
|
84,483
|
|
|
(346,196
|
)
|
|
|
317,950
|
|
|
|
Interest income (expense), net
|
|
|
(326
|
)
|
|
|
2,228
|
|
|
1,961
|
|
|
|
9,192
|
|
Other income (loss)
|
|
|
1,095
|
|
|
|
4,265
|
|
|
25,347
|
|
|
|
11,506
|
|
Total other income, net
|
|
|
769
|
|
|
|
6,4932
|
|
|
7,308
|
|
|
|
20,698
|
|
|
|
Income (loss) before income taxes
|
|
|
(215,289
|
)
|
|
|
90,976
|
|
|
(318,888
|
)
|
|
|
338,648
|
|
|
|
Income taxes
|
|
|
4,451
|
|
|
|
38,365
|
|
|
2,399
|
|
|
|
123,211
|
|
|
|
Net (loss) income
|
|
$
|
(219,740
|
)
|
|
$
|
52,611
|
|
$
|
(321,287
|
)
|
|
$
|
215,437
|
|
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(1.27
|
)
|
|
$
|
0.30
|
|
$
|
(1.84
|
)
|
|
$
|
1.19
|
|
Diluted
|
|
$
|
(1.27
|
)
|
|
$
|
0.29
|
|
$
|
(1.84
|
)
|
|
$
|
1.19
|
|
|
|
Average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
173,290
|
|
|
|
177,927
|
|
|
174,598
|
|
|
|
180,474
|
|
Diluted
|
|
|
173,290
|
|
|
|
178,965
|
|
|
174,598
|
|
|
|
181,395
|
|
Molex Incorporated
|
|
Consolidated Statements of Cash Flows
|
|
(in thousands)
|
|
|
|
Years Ended June 30,
|
|
|
|
2009
|
|
2008
|
|
2007
|
|
Operating activities:
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
(321,287
|
)
|
|
$
|
215,437
|
|
|
$
|
240,768
|
|
|
Add (deduct) non-cash items included in net income:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
251,902
|
|
|
|
252,344
|
|
|
|
237,912
|
|
|
Goodwill impairment
|
|
|
264,140
|
|
|
-
|
|
|
-
|
|
|
Asset write-downs included in restructuring costs
|
|
|
41,376
|
|
|
|
13,599
|
|
|
|
8,667
|
|
|
(Gain) loss on investments
|
|
|
(143
|
)
|
|
|
111
|
|
|
|
(1,154
|
)
|
|
Deferred income taxes
|
|
|
(26,606
|
)
|
|
|
31,096
|
|
|
|
20,998
|
|
|
Loss (gain) on sale of property, plant and equipment
|
|
|
2,478
|
|
|
|
296
|
|
|
|
1,800
|
|
|
Share-based compensation
|
|
|
26,508
|
|
|
|
24,24
|
|
|
|
927,524
|
|
|
Other non-cash items
|
|
|
(8,124
|
)
|
|
|
(6,778
|
)
|
|
|
23,373
|
|
|
Changes in assets and liabilities, excluding effects of foreign
|
|
|
|
|
|
|
|
|
currency adjustments and acquisitions:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
201,080
|
|
|
|
478
|
|
|
|
27,913
|
|
|
Inventories
|
|
|
95,529
|
|
|
|
(26,240
|
)
|
|
|
(16,514
|
)
|
|
Accounts payable
|
|
|
(84,502
|
)
|
|
|
34,197
|
|
|
|
(57,479
|
)
|
|
Other current assets and liabilities
|
|
|
(24,967
|
)
|
|
|
(45,798
|
)
|
|
|
(60,421
|
)
|
|
Other assets and liabilities
|
|
|
(47,486
|
)
|
|
|
(13,857
|
)
|
|
|
(1,953
|
)
|
|
Cash provided from operating activities
|
|
|
369,898
|
|
|
|
479,134
|
|
|
|
451,434
|
|
|
|
|
|
Investing activities:
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(177,943
|
)
|
|
|
(234,626
|
)
|
|
|
(296,861
|
)
|
|
Proceeds from sales of property, plant and equipment
|
|
|
9,574
|
|
|
|
14,978
|
|
|
|
9,946
|
|
|
Proceeds from sales or maturities of marketable securities
|
|
|
29,549
|
|
|
|
811,724
|
|
|
|
4,856,301
|
|
|
Purchases of marketable securities
|
|
|
(42,751
|
)
|
|
|
(764,966
|
)
|
|
|
(4,785,080
|
)
|
|
Acquisitions, net of cash acquired
|
|
|
(74,789
|
)
|
|
|
(42,503
|
)
|
|
|
(238,072
|
)
|
|
Other investing activities
|
|
|
3,274
|
|
|
|
(2,763
|
)
|
|
|
7,637
|
|
|
Cash used for investing activities
|
|
|
(253,086
|
)
|
|
|
(218,156
|
)
|
|
|
(446,129
|
)
|
|
|
|
|
Financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from revolving credit facility and short-term loans
|
|
|
245,000
|
|
|
|
139,590
|
|
|
|
44,000
|
|
|
Payments on revolving credit facility
|
|
|
(295,000
|
)
|
|
|
(75,000
|
)
|
|
|
(44,000
|
)
|
|
Proceeds from issuance of long-term debt
|
|
|
78,060
|
|
|
-
|
|
|
|
131,045
|
|
|
Payments of long-term debt
|
|
|
(1,827
|
)
|
|
|
(1,948
|
)
|
|
|
(26,937
|
)
|
|
Cash dividends paid
|
|
|
(99,640
|
)
|
|
|
(74,598
|
)
|
|
|
(55,176
|
)
|
|
Exercise of stock options
|
|
|
1,692
|
|
|
|
16,732
|
|
|
|
15,416
|
|
|
Excess tax benefits from share-based compensation
|
|
|
1,693
|
|
|
|
1,677
|
|
|
|
1,714
|
|
|
Purchase of treasury stock
|
|
|
(76,342
|
)
|
|
|
(199,583
|
)
|
|
|
(34,889
|
)
|
|
Other financing activities
|
|
|
(9,218
|
)
|
|
|
(4,176
|
)
|
|
|
(2,644
|
)
|
|
Cash (used for) provided from financing activities
|
|
|
(155,582
|
)
|
|
|
(197,306
|
)
|
|
|
28,529
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
(12,030
|
)
|
|
|
33,474
|
|
|
|
11,712
|
|
|
Net (decrease) increase in cash and cash equivalents
|
|
|
(50,800
|
)
|
|
|
97,146
|
|
|
|
45,546
|
|
|
Cash and cash equivalents, beginning of year
|
|
|
475,507
|
|
|
|
378,361
|
|
|
|
332,815
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
424,707
|
|
|
$
|
475,507
|
|
|
$
|
378,361
|
|
Molex Incorporated
Steve Martens
Vice President of Investor
Relations
(630) 527-4344